Abstract:Bacillus strains are widely used as
biological
control agents to protect plants from fungal pathogens. However, whether Bacillus can exploit fungal pathogens to increase its biocontrol
efficacy remains largely unexplored. Here, Bacillus
atrophaeus NX-12 showed a high inhibition efficacy
against Fusarium oxysporum f. sp. cucumerinum
(FOC). The primary extracellular antifungal component of B. atrophaeus NX-12 was identified as fengycin by
matrix-assisted laser desorption/ionization–time-of-flight-mass
spectromet… Show more
“…Xue et al found that the lipopeptide fengycin was also able to oxidative stress F. oxysporum, which is the same as our findings …”
Section: Resultssupporting
confidence: 92%
“…Xue et al found that the lipopeptide fengycin was also able to oxidative stress F. oxysporum, which is the same as our findings. 43 Disruption of the Mitochondrial Structure and Membrane Potential by the Antifungal Peptide P852. Transmission electron microscopy was utilized to observe the structural changes in the mitochondria of F. oxysporum after 12 h of P852 treatment.…”
“…Xue et al found that the lipopeptide fengycin was also able to oxidative stress F. oxysporum, which is the same as our findings …”
Section: Resultssupporting
confidence: 92%
“…Xue et al found that the lipopeptide fengycin was also able to oxidative stress F. oxysporum, which is the same as our findings. 43 Disruption of the Mitochondrial Structure and Membrane Potential by the Antifungal Peptide P852. Transmission electron microscopy was utilized to observe the structural changes in the mitochondria of F. oxysporum after 12 h of P852 treatment.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.